Case StudyIndian Journal of Pharmacy PracticeVol. 10 | Issue 2 | pp. 147–150Open access
Cabergoline Induced Supraventricular Tachycardia with QT Prolongation
- 1*,
- 2,
- 3,
- 4,
- 5,
- 6
- 1 Doctoral Research Scholar, Department of Clinical Pharmacy, JSS Medical College and Hospital, JSS University, Mysore, Karnataka, INDIA.
- 2 PharmD Intern, Department of Clinical Pharmacy, JSS Medical College and Hospital, JSS University, Mysore, Karnataka, INDIA.
- 3 Senior Resident, Department of General Medicine, JSS Medical College and Hospital, JSS University, Mysore, Karnataka, INDIA.
- 4 Associate Professor, Department of General Medicine, JSS Medical College and Hospital, JSS University, Mysore, Karnataka, INDIA.
- 5 Professor and Dean, Department of General Medicine, JSS Medical College and Hospital, JSS University, Mysore, Karnataka, INDIA.
- 6 Professor and Head, Department of Clinical Pharmacy, JSS Medical College and Hospital, JSS University, Mysore, Karnataka, INDIA.
Published in Indian Journal of Pharmacy Practice
Correspondence: Vineetha Bharathan Menon
Doctoral Research Scholar, Department of Clinical Pharmacy, JSS Medical College and Hospital, JSS University, Mysore, Karnataka, INDIA.
Email: vineethamenon54@yahoo.com
- DOI:
- 10.5530/ijopp.10.2.30
How to cite
Menon, V. B., Gaddipati, B., R, V. C., Pereira, P., Gowdappa, H. B., & Ramesh, M. Cabergoline Induced Supraventricular Tachycardia with QT Prolongation. Indian Journal of Pharmacy Practice, 10(2), 147–150. https://doi.org/10.5530/ijopp.10.2.30
Abstract
Background: Cabergoline is commonly known to cause valvular disorders. Cases of supraventricular tachycardia with QT prolongation are seen, albeit, extremely rare. Aim: We report a case of supraventricular tachycardia with QT prolongation presumed secondary to cabergoline use. Clinical Details: A 30-year-old post-partal female complained of palpitation and syncope after two days of cabergoline usage. Her past medical history was insignificant. Electrocardiogram showed QT prolongation of 489 ms. Based on her presentation, we presume that the patient’s condition was the result of cabergoline. Outcomes: Causality assessment was suggestive of a probable relationship between the patient’s symptoms and her use of cabergoline. Symptoms improved significantly after the offending drug was withdrawn with an objective reduction in QTc. Conclusion: Electrocardiogram should be monitored in individuals receiving more than one QT prolonging medication or with symptoms of arrhythmia or are at high risk of QT prolongation/Torsades de Pointes.
Keywords
Subject
Article metadata
| Title | Cabergoline Induced Supraventricular Tachycardia with QT Prolongation |
|---|---|
| Authors | Vineetha Bharathan Menon; Bhanuvaishnavi Gaddipati; Venkatesh C R; Pratibha Pereira; Hathur Basavanna Gowdappa; Madhan Ramesh |
| Affiliations | Doctoral Research Scholar, Department of Clinical Pharmacy, JSS Medical College and Hospital, JSS University, Mysore, Karnataka, INDIA.; PharmD Intern, Department of Clinical Pharmacy, JSS Medical College and Hospital, JSS University, Mysore, Karnataka, INDIA.; Senior Resident, Department of General Medicine, JSS Medical College and Hospital, JSS University, Mysore, Karnataka, INDIA.; Associate Professor, Department of General Medicine, JSS Medical College and Hospital, JSS University, Mysore, Karnataka, INDIA.; Professor and Dean, Department of General Medicine, JSS Medical College and Hospital, JSS University, Mysore, Karnataka, INDIA.; Professor and Head, Department of Clinical Pharmacy, JSS Medical College and Hospital, JSS University, Mysore, Karnataka, INDIA. |
| Corresponding author | vineethamenon54@yahoo.com |
| Journal | Indian Journal of Pharmacy Practice |
| Volume / Issue | Vol. 10, Issue 2 |
Also in this issue
- Denguepp. 68
- Antimicrobial Resistance: Identifying the Major Conflicts of Interest and Way Forwardpp. 69–77
- Assessment of Medication Adherence to JNC-7 Guidelines and Risk Factors for Hypertension in a South Indian Tertiary Care Hospitalpp. 78–89
- Acute Complications Associated With Haemodialysis in a CKD Cohort Populationpp. 90–95
- Study on Steroid Utilization Pattern in a Tertiary Care Teaching Hospitalpp. 96–103